Cathie Wood's $362 Million CRISPR Bet: Hidden Catalyst
Cathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
Verify budget accuracy with practical checks that align your projected spending to actuals. This quick intro helps you spot misalignments and tighten your budget.
11,585 articlesCathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
NVIDIA just revealed owns a notable minority stake in Nebius, triggering a sharp stock move. This article breaks down...
California gas prices surged by 40 cents in two weeks, lifting the statewide average to $4.58 per gallon. This report...
Imagine turning a modest $100 monthly investment into a meaningful future. This guide breaks down how a stock that co...
A new poll of voters 50+ shows persistent anxiety about retirement readiness among older women, with health costs and...
Bill Gates manages a massive charitable portfolio with a striking concentration: about 30% of its value sits in a sin...
Anthropic's $200 million DoD contract is under scrutiny after reports about Claude's deployment in a January raid. Th...
Healthcare REITs offer income, but they carry unique risks. Learn how to evaluate Medical Properties Trust with actio...
When a top executive sells shares as a company commits billions to its hubs, it can spark questions. This article bre...
A notable stake change in Victoria’s Secret & Co. raises questions for investors. This article explains what the capi...
As orthofix prepares its 2025 earnings narrative, investors weigh product mix shifts, margins, and macro headwinds. T...
When an investment firm Absoluto Partners reveals a fresh stake in MercadoLibre, traders take note. This in-depth gui...